5/17
01:55 pm
hae
Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid [Yahoo! Finance]
Low
Report
Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid [Yahoo! Finance]
5/17
12:00 pm
hae
Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue? [Yahoo! Finance]
Low
Report
Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue? [Yahoo! Finance]
5/14
11:02 am
hae
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
Low
Report
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
5/10
04:07 pm
hae
Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
5/10
01:37 pm
hae
Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at JMP Securities from $115.00 to $125.00. They now have a "market outperform" rating on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at JMP Securities from $115.00 to $125.00. They now have a "market outperform" rating on the stock.
5/10
01:02 pm
hae
Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand [Yahoo! Finance]
Low
Report
Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand [Yahoo! Finance]
5/10
11:24 am
hae
Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at Barrington Research from $105.00 to $107.00. They now have an "outperform" rating on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at Barrington Research from $105.00 to $107.00. They now have an "outperform" rating on the stock.
5/10
08:39 am
hae
Haemonetics Co. (NYSE: HAE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Haemonetics Co. (NYSE: HAE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
5/9
11:49 am
hae
Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Medium
Report
Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
5/9
06:00 am
hae
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
Low
Report
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
5/1
01:32 pm
hae
Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs [Yahoo! Finance]
Low
Report
Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs [Yahoo! Finance]
5/1
08:39 am
hae
Apheresis Market is Expected to Reach $3.9 billion | MarketsandMarkets™ [Yahoo! Finance]
Low
Report
Apheresis Market is Expected to Reach $3.9 billion | MarketsandMarkets™ [Yahoo! Finance]
4/29
11:00 am
hae
Global $3.9 Bn Apheresis Market Forecast to 2029: Surge in Use for Leukaemia and Paediatric Patients Boosts Growth Prospects [Yahoo! Finance]
Low
Report
Global $3.9 Bn Apheresis Market Forecast to 2029: Surge in Use for Leukaemia and Paediatric Patients Boosts Growth Prospects [Yahoo! Finance]
4/12
11:09 am
hae
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.
4/12
11:02 am
hae
Why You Should Add Haemonetics (HAE) to Your Portfolio Now [Yahoo! Finance]
Low
Report
Why You Should Add Haemonetics (HAE) to Your Portfolio Now [Yahoo! Finance]
4/12
10:38 am
hae
Apheresis Market Worth $3.9 billion | MarketsandMarkets™ [Yahoo! Finance]
Low
Report
Apheresis Market Worth $3.9 billion | MarketsandMarkets™ [Yahoo! Finance]
4/10
05:07 pm
hae
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 [Yahoo! Finance]
Low
Report
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 [Yahoo! Finance]
4/10
04:58 pm
hae
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
Low
Report
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
4/5
11:59 am
hae
Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval [Yahoo! Finance]
Low
Report
Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval [Yahoo! Finance]
4/4
06:34 am
hae
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge [Yahoo! Finance]
Low
Report
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge [Yahoo! Finance]
4/4
06:30 am
hae
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
Low
Report
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
4/1
08:19 am
hae
Haemonetics Corporation Completes Acquisition of Attune Medical [Yahoo! Finance]
Low
Report
Haemonetics Corporation Completes Acquisition of Attune Medical [Yahoo! Finance]
4/1
08:00 am
hae
Haemonetics Corporation Completes Acquisition of Attune Medical
Low
Report
Haemonetics Corporation Completes Acquisition of Attune Medical
3/29
10:47 am
hae
Haemonetics (HAE) Crossed Above the 200-Day Moving Average: What That Means for Investors [Yahoo! Finance]
Low
Report
Haemonetics (HAE) Crossed Above the 200-Day Moving Average: What That Means for Investors [Yahoo! Finance]
3/22
11:03 pm
hae
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.